Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARC1102 in Allergic Conjunctivitis
NCT01320553Phase 2Completed
- Sponsor
- Sun Pharma
- Start
- Jun 2011
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SPARC1102 in allergic conjunctivitis (AC), sponsored by Sun Pharma. Started Jun 2011; status: completed.
02
Drugs
SPARC1102
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT01320553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01320553.